Despite raising its outlook on July 18, shares of UnitedHealth (UNH) fell to $232.94 recently. The stock failed to break out above $250 throughout this month. Should investors ignore the JPMorgan hospital survey that suggests a weak third-quarter ahead? Or might investors trust that UnitedHealth meets its strong forecast in the upcoming quarterly report?
In July, JPMorgan conducted a hospital survey that indicated persistently high medical services usage. This could increase the medical loss ratios for companies like UnitedHealth, Anthem (ANTM), or Humana (HUM). This survey is running